# ILLUMENATE EU Randomized Clinical Trial

Study · id `cardio:ct-nct01858363` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01858363](<https://clinicaltrials.gov/study/NCT01858363>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01858363

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 294 participants.

## Technical summary

Registry record NCT01858363. Randomized; single masking; primary purpose treatment. Start 2012-11 (registry gives no type); primary completion 2016-03 (actual). Results posted on 2021-10-13.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 294 participants (enrolled count; ClinicalTrials.gov record NCT01858363, source copy `cardio:ctgov-nct01858363-2021-10-13`, retrieved 2026-10-31)
- Start date: 2012-11 (registry gives no type) (ClinicalTrials.gov record NCT01858363, source copy `cardio:ctgov-nct01858363-2021-10-13`, retrieved 2026-10-31)
- Primary completion: 2016-03 (actual) (ClinicalTrials.gov record NCT01858363, source copy `cardio:ctgov-nct01858363-2021-10-13`, retrieved 2026-10-31)
- Completion: 2020-10 (actual) (ClinicalTrials.gov record NCT01858363, source copy `cardio:ctgov-nct01858363-2021-10-13`, retrieved 2026-10-31)
- Results first posted: 2021-10-13 (ClinicalTrials.gov record NCT01858363, source copy `cardio:ctgov-nct01858363-2021-10-13`, retrieved 2026-10-31)
- Countries: Germany (ClinicalTrials.gov record NCT01858363, source copy `cardio:ctgov-nct01858363-2021-10-13`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01858363-2021-10-13`, retrieved 2026-10-31)

## The registry's words

- Brief title: ILLUMENATE EU Randomized Clinical Trial
- Acronym: EU RCT
- Condition: Peripheral Arterial Disease
- Condition: Claudication
- Intervention (Device): CVI Paclitaxel-coated Percutaneous Transluminal Angioplasty Balloon Catheter
- Intervention (Device): Bare Percutaneous Transluminal Angioplasty Balloon Catheter
- Lead sponsor: Spectranetics Corporation
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Spectranetics Corporation (`cardio:org-spectranetics-corporation`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: Low-Dose Paclitaxel-Coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease: One-Year Results of the ILLUMENATE European Randomized Clinical Trial (Randomized Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon) (`cardio:pubmed-28424223`)
- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: Sustainable Antirestenosis Effect With a Low-Dose Drug-Coated Balloon: The ILLUMENATE European Randomized Clinical Trial 2-Year Results (`cardio:pubmed-30522663`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: f6aa3b760c34c824eb9e0e19e6d805dd7f24871897c2911d8942236a356c7590
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
